Effects of diuretics on plasma lipoproteins in healthy men.
D000284:Administration, Oral; D000328:Adult; D002752:Chlorthalidone / Q000008:administration & dosage; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D004232:Diuretics; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005665:Furosemide / Q000008:administration & dosage; D006801:Humans; D006852:Hydrochlorothiazide / Q000008:administration & dosage; D008074:Lipoproteins / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood*; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D010743:Phospholipids / Q000097:blood; D010919:Placebos; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology*
D004232:Diuretics; D005230:Fatty Acids, Nonesterified; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D010743:Phospholipids; D010919:Placebos; D049993:Sodium Chloride Symporter Inhibitors; D006852:Hydrochlorothiazide; D005665:Furosemide; D002784:Cholesterol; D002752:Chlorthalidone